Back
Endava PLC Vs. Cidara Therapeutics Industry Stock Comparison
Sell
37
DAVA
Endava PLC
Last Price:
$13.73
Seasonality Move:
3.37%
Buy
74
CDTX
Cidara Therapeutics
Last Price:
$50.58
Seasonality Move:
-8.55%
Sell
37
Endava PLC (DAVA)
is a Sell
Is Endava PLC a Buy, Sell or Hold?
-
The current Endava PLC [DAVA] share price is $14.09. The Score for DAVA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.88. The Score for CDTX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava PLC's stock price today?
-
The Endava PLC share price today is $14.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVA is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 37.76 | Sell |
Chaikin Money Flow: | -892583 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.52 - 16.18) | Sell |
Bollinger Bands (100): | (14.48 - 23.54) | Sell |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.94 | Buy |
Relative Strength Index (14 RSI): | 78.66 | Buy |
Chaikin Money Flow: | 21664 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.13 - 49.33) | Buy |
Bollinger Bands (100): | (16.07 - 34.69) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.14 | Sell |
20-day SMA: | 15.09 | Sell |
50-day SMA: | 16.16 | Sell |
200-day SMA: | 23.81 | Sell |
8-day EMA: | 14.9 | Sell |
20-day EMA: | 15.15 | Sell |
50-day EMA: | 15.11 | Sell |
200-day EMA: | 8.98 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.37 | Buy |
20-day SMA: | 39.67 | Buy |
50-day SMA: | 29.45 | Buy |
200-day SMA: | 21.42 | Buy |
8-day EMA: | 48.69 | Buy |
20-day EMA: | 42.07 | Buy |
50-day EMA: | 33.2 | Buy |
200-day EMA: | 23.39 | Buy |
Endava PLC Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.14 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Endava PLC Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |